MediWound raises $20 million from Israeli institutions
Clal Biotech: There is little chance that Gamida Cell will carry out a new clinical trial; the holding is no longer material.
By GALI WEINREB, GLOBESDollar bills 150(photo credit: Steve Marcus / Reuters)
.
if(catID != 151){
var cont = `Take Israel home with the new Jerusalem Post Store
